Watchlist Price Alert

(XBI)

AMEX: XBI · Real-Time Price · USD

83.50

1.00 (1.21%)

At close: May 02, 2025, 3:59 PM

83.55

0.05%

After-hours: May 02, 2025, 05:52 PM EDT

1.21% (1D)

Bid	83.51
Market Cap	5.15B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	n/a
PE Ratio (ttm)	n/a
Forward PE	n/a
Analyst	n/a

Ask	83.7
Volume	9,295,004
Avg. Volume (20D)	10,800,988
Open	83.56
Previous Close	82.50
Day's Range	83.25 - 84.24
52-Week Range	66.66 - 105.47
Beta	undefined

About XBI

A detailed description of the company is not yet available....

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange undefined

Ticker Symbol XBI

Full Company Profile

News

3 weeks ago · youtube.com

Sell into strength in pharma, says Mizuho's Jared Holz

Jared Holz, Mizuho, joins 'Fast Money' to talk a rebound in biotech stocks and what new tariffs mean for the pharmaceuticals space.

3 weeks ago · zacks.com

Should You Invest in the SPDR S&P Biotech ETF (XBI)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on 01/31/2006...

1 month ago · nypost.com

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official was forced to resign, the most high-profile exit at the regulator as the Trump admin...

1 month ago · youtube.com

Trade Tracker: Joe Terranova sells the XBI, buys Amgen

Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.

1 month ago · zacks.com

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

The SPDR S&P Biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

2 months ago · seekingalpha.com

Invest In A New Biotech Bull Market With XBI And IBB

Biotech stocks are oversold. This near-term bottom might be the start of a long-term bull run. IBB and XBI offer different advantages. IBB can benefit from the flight to safety trade. XBI provides mor...

2 months ago · etftrends.com

Can Health Care ETFs Aid Your Portfolio?

The Health Care Select Sector SPDR ETF (XLV) was up approximately 6% year-to-date as of January 29. While it is still early days, this performance is already twice as robust as the sector ETF's perfor...